<DOC>
	<DOCNO>NCT02273440</DOCNO>
	<brief_summary>To evaluate effect multiple dos BIIL 284 BS pharmacokinetics single dose theophylline .</brief_summary>
	<brief_title>Effect BIIL 284 BS Pharmacokinetics Theophylline Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Theophylline</mesh_term>
	<criteria>Written inform consent sign date prior participation study ( include medication washout ) All volunteer study healthy male , age 1850 year ( inclusive ) willing use condom 60 day last dose All volunteer within + 20 % ideal body weight ( Metropolitan Scale , 1983 ) Nonsmokers ( volunteer never smoke ) exsmokers least one year smoking history , great five packyears ( 1 pack year = 20 cigarette per day one year ) Ability comply concomitant therapy restriction Volunteers prescription drug . O.T.C . drug must discontinue least two week prior first dose study drug . If throughout study , volunteer need O.T.C . medication , investigator call clinical monitor review casebycase base . Restrictions different medication apply Volunteers evidence clinically relevant concomitant disease base upon complete medical history , physician global assessment , complete physical examination , ECG , clinical laboratory test Viral respiratory tract infection , respiratory tract infection within six week precede first day dose study medication Small difficult locate arm hand vein would impair clinician 's ability draw blood sample place venous catheter Volunteers know drug alcohol dependence ( presence dependency 10 year ) drink 60 g alcohol per day History significant allergic reaction drug sensitivity aspirin positive drug screen Use investigational new drug precede 3 month six halflives ( whichever great ) prior first screen Visit 1 Donation blood precede 3 month Visit 1 Volunteers receive hyposensitization therapy stable dose last three month Visit 1 Volunteers know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological , hormonal disorder Volunteers disease central nervous system ( epilepsy ) psychiatric disorder Volunteers know history orthostatic hypotension , faint spell blackouts Volunteers chronic relevant acute infection Volunteers history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Volunteers eosinophilia &gt; 7 % Volunteers receive drug might influence result trial week previous start study Volunteers participate excessive physical activity ( e.g . competitive sport ) within last week study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>